Fintel · Oct 2, 2026
OS
NYSE · OSCR
Oscar Health, Inc.
Healthcare · Medical - Healthcare Plans
$33.37
Up+$0.27 (+0.82%)
Updated Oct 10, 2026, 8:00 PM
SID Score
6.4/10
Composite research score
Smart Money
62/100
Neutral
- Market cap
- 4.05B
- P/E ratio
- -16.61
- Dividend yield
- 0.00%
- 52-week range
- $10.69 – $34.48
- Volume
- 5.32M
- Avg. volume
- 16.31M
Price performance · OSCR
OSCR price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
OSCR closed at $33.37 after 21 trading sessions, up 1.83% for the selected period.
- Last close
- $33.37
- Period change
- +1.83%
- Period low
- $28.87
- Period high
- $33.81
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $33.16 | $34.14 | $32.69 | $33.37 | 5.32M |
| Oct 8, 2026 | $32.75 | $33.42 | $32.25 | $33.10 | 4.13M |
| Oct 7, 2026 | $32.03 | $33.51 | $31.80 | $32.91 | 5.43M |
| Oct 6, 2026 | $32.53 | $32.8399 | $32.02 | $32.34 | 4.89M |
| Oct 5, 2026 | $30.97 | $32.665 | $30.84 | $32.42 | 4.68M |
| Oct 2, 2026 | $29.82 | $31.17 | $29.69 | $30.94 | 3.91M |
| Oct 1, 2026 | $30.695 | $31.0584 | $29.73 | $29.90 | 3.94M |
| Sep 30, 2026 | $29.745 | $30.99 | $29.52 | $30.84 | 5.45M |
| Sep 29, 2026 | $29.73 | $29.83 | $28.99 | $29.77 | 3.8M |
| Sep 28, 2026 | $29.51 | $30.24 | $29.20 | $29.65 | 4.01M |
| Sep 25, 2026 | $29.02 | $29.98 | $28.80 | $29.60 | 4.9M |
| Sep 24, 2026 | $30.30 | $30.70 | $28.30 | $28.87 | 5.79M |
| Sep 23, 2026 | $30.38 | $30.89 | $29.80 | $30.53 | 5.53M |
| Sep 22, 2026 | $31.47 | $31.475 | $29.22 | $30.67 | 8.24M |
| Sep 21, 2026 | $31.00 | $32.16 | $30.37 | $31.29 | 8.43M |
| Sep 18, 2026 | $32.24 | $33.18 | $31.28 | $32.13 | 9.46M |
| Sep 17, 2026 | $33.145 | $34.12 | $31.88 | $31.98 | 5.6M |
| Sep 16, 2026 | $33.50 | $33.625 | $30.75 | $32.34 | 6.3M |
| Sep 15, 2026 | $33.50 | $33.72 | $32.30 | $32.44 | 4.27M |
| Sep 14, 2026 | $33.02 | $34.48 | $32.83 | $33.81 | 5.14M |
| Sep 11, 2026 | $33.04 | $34.23 | $32.58 | $32.77 | 7.1M |
Latest OSCR news
The latest Smart Investors Daily articles mentioning OSCR.
Stock researchCompany · Overview
Company
Market Activity
Research & News
OSCR research
Overview
Company profile and research snapshot.
Company profile
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $14.67
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 18, 2026 | Raymond James | Outperform | — |
| Sep 17, 2026 | Stephens & Co. | Equal-Weight | — |
| Sep 17, 2026 | Barclays | Overweight | — |
| Sep 17, 2026 | Baird | Neutral | — |
| Sep 17, 2026 | B of A Securities | Underperform | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 1, 2026
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts
Oscar Health, Inc. (OSCR) reached $29.9 at the closing of the latest trading day, reflecting a -3.05% change compared to its last close.
Yahoo · Sep 28, 2026
Is Oscar Health (OSCR) Cheap After Its EPS Roadmap And New Product Push?
Oscar Health (OSCR) has drawn fresh attention after management highlighted a roadmap to higher earnings per share, tied to medical loss ratio discipline and new offerings such as the Lucy Healthcare Marketplace and AI powered tools. Recent trading has been choppy for Oscar Health, with the share price slipping 5.40% over seven days and 2.86% over 30 days. However, a 3.79% 90 day share price return and a 97.73% year to date share price return suggest momentum has been building over a longer...
Yahoo · Sep 27, 2026
Oscar Health (OSCR) Stock Looks Cheap Relative To Its Earnings Path
Oscar Health has been on a powerful run in recent years, yet the real question for you today is whether the current share price lines up with what its earnings story can reasonably support. The stock has also seen shorter term pullbacks, which makes the earnings backdrop even more important for anyone trying to judge what they are actually paying for. Over the past 3 years the stock has delivered a very large gain of about 4.3x, which puts a lot of weight on whether the underlying earnings...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
